Skip to content

The Effect of a Low Sodium-High Potassium Salt on Blood Pressure in Vietnamese Adults

The Effect of a Low Sodium-High Potassium Salt on Blood Pressure in Vietnamese Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02016404
Enrollment
180
Registered
2013-12-20
Start date
2013-06-30
Completion date
2013-09-30
Last updated
2013-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

blood pressure, sodium, salt, low sodium high potassium salt, potassium, Vietnam, randomized controlled trial

Brief summary

The purpose of this study was to investigate the effects of low-sodium, high-potassium condiments and salt on blood pressure in untreated (pre)hypertensive Vietnamese adults.

Interventions

OTHERLow-sodium, high-potassium salt

Iodized low-sodium, high-potassium botcanh (a traditional mixture of salt, MSG, sugar and herbs) plus and iodized low-sodium, high-potassium salt for home food preparation

Regular iodized high-sodium botcanh (a traditional mixture of salt, MSG, sugar and herbs) and high-sodium salt

Sponsors

National Institute of Nutrition, Vietnam
CollaboratorOTHER_GOV
Wageningen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

Untreated prehypertension or mild hypertension (systolic BP between 130 and 160 mmHg and/or diastolic BP between 85 and 100 mmHg) based on the mean of two measurements with a 1-week interval

Exclusion criteria

Diagnosed or self-reported cardiovascular disease Diagnosed or self-reported kidney disease

Design outcomes

Primary

MeasureTime frameDescription
Change in office systolic blood pressure (SBP)Change during 8 weeks of interventionBased on repeated measurements with a digital BP device (OMRONHEM 762) using the standard protocol of WHO STEP guideline at week 0, 2, 4 6 and 8.

Secondary

MeasureTime frameDescription
Change in office diastolic blood pressure (DBP)Change during 8 weeks of interventionBased on repeated measurements with a digital BP device (OMRONHEM 762) using the standard protocol of WHO STEP guideline at week 0, 2, 4, 6 and 8.

Other

MeasureTime frame
Change in body weightChange during 8 weeks of intervention
Change in 24-hour urinary calcium excretionChange during 8 weeks of intervention
Change in 24-hour urinary iodine excretionChange during 8 weeks of intervention
Change in 24-hour urinary sodium excretionChange during 8 weeks of intervention
Change in 24-hour urinary proteinChange during 8 weeks of intervention
Change in heart rateChange during 8 weeks of intervention
Change in 24-hour urinary creatinine excretionChange during 8 weeks of intervention
Change in 24-hour urinary potassium excretionChange during 8 weeks of intervention

Countries

Vietnam

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026